{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:17:13Z","timestamp":1790738233165,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.preteyeres.2014.04.002","type":"journal-article","created":{"date-parts":[[2014,5,10]],"date-time":"2014-05-10T03:46:45Z","timestamp":1399693605000},"page":"27-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"special_numbering":"C","title":["The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies"],"prefix":"10.1016","volume":"42","author":[{"given":"Roc\u00edo","family":"Herrero-Vanrell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bravo-Osuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Andr\u00e9s-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Vicario-de-la-Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Teresa","family":"Molina-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2014.04.002_bib1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archopht.1979.01020020075018","article-title":"Drainage of microspheres and RBCs from the vitreous of aphakic and phakic eyes","volume":"97","author":"Algvere","year":"1979","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib2","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1211\/jpp.57.12.0005","article-title":"Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration","volume":"57","author":"Amrite","year":"2005","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib3","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1167\/iovs.05-0531","article-title":"Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage","volume":"47","author":"Amrite","year":"2006","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib4","series-title":"Dexamethasone Sustained Delivery From Polyesteramide Microspheres for Intraocular Administration. Influence of Sterilization","author":"Andr\u00e9s-Guerrero","year":"2013"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib5","first-page":"1002","article-title":"Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1\/rd1 mouse","volume":"11","author":"Andrieu-Soler","year":"2005","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib6","series-title":"XXV Symposium of the European Society for Biomaterials, Madrid, Spain","article-title":"Preclinical testing of compounds and intraocular drug delivery systems using an organ retinal culture. PANOPTES: challenges and new perspectives in ophthalmic applications","author":"Arango-Gonz\u00e1lez","year":"2013"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib7","first-page":"184","article-title":"Biodegradable additives modulate ganciclovir release rate from PLGA microspheres destined to intraocular administration","volume":"2","author":"Barcia","year":"2005","journal-title":"Lett. Drug. Des."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.exer.2009.03.012","article-title":"Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone","volume":"89","author":"Barcia","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0168-3659(98)00170-9","article-title":"Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation","volume":"59","author":"Bittner","year":"1999","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib10","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1018822002353","article-title":"pH and osmotic pressure inside biodegradable microspheres during erosion","volume":"16","author":"Brunner","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib11","first-page":"675","article-title":"Intravitreal Bioerudivel sustained-release triamcinolone microspheres system (RETAAC). Preliminary report of its potential usefulness for the treatment of diabetic macular edema","volume":"81","author":"Cardillo","year":"2006","journal-title":"Arch. Soc. Esp. Oftalmol."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1167\/iovs.01-1156","article-title":"Controlled delivery of anti-VEGF aptamer EYE 001 with poly(lactic-co-glucolic) acid microspheres","volume":"44","author":"Carrasquillo","year":"2003","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00006982-198400410-00009","article-title":"Vitreous substitute. Experimental studies and review","volume":"4","author":"Chan","year":"1984","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2011.06.023","article-title":"Retinal ganglion cells survival in a glaucoma model by GDNF\/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure","volume":"156","author":"Checa-Casalengua","year":"2011","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ijpharm.2012.07.019","article-title":"Preservation of biological activity of glial cell line-derived neurotrophic factor (GDNF) after microencapsulation and sterilization by gamma irradiation","volume":"436","author":"Checa-Casalengua","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1081\/PDT-100100542","article-title":"Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery","volume":"5","author":"Chowdhury","year":"2000","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0928-0987(97)00023-7","article-title":"Biodegradable microspheres for the intravitreal administration of acyclovir: in\u00a0vitro\/in\u00a0vivo evaluation","volume":"5","author":"Conti","year":"1997","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0378-5173(96)04606-6","article-title":"Degradation of DL-PLA-methadone microspheres during in\u00a0vitro release","volume":"140","author":"Delgado","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1089\/jop.2006.132","article-title":"Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis","volume":"23","author":"Duvvuri","year":"2007","journal-title":"J.\u00a0Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jconrel.2004.10.015","article-title":"Microencapsulation by solvent extraction\/evaporation: reviewing the state of the art of microsphere preparation process technology","volume":"102","author":"Freitas","year":"2005","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/092739490500192","article-title":"A\u00a0review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation","volume":"12","author":"Gaudio","year":"2004","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib23","first-page":"2743","article-title":"Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR","volume":"34","author":"Giordano","year":"1993","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3109\/02713689508995797","article-title":"Biodegradation and tissue reaction to intravitreous biodegradable poly(D,L-lactic-co-glycolic)acid microspheres","volume":"14","author":"Giordano","year":"1995","journal-title":"Curr. Eye Res."},{"issue":"112","key":"10.1016\/j.preteyeres.2014.04.002_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jconrel.2006.02.010","article-title":"Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery","volume":"30","author":"Gomes Dos Santos","year":"2006","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0142-9612(95)93258-F","article-title":"Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence","volume":"16","author":"Grizzi","year":"1995","journal-title":"Biomaterials"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib27","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1167\/iovs.05-1373","article-title":"Cyclosporine-loaded microspheres for treatment of uveitis: in\u00a0vitro characterization and in\u00a0vivo pharmacokinetic study","volume":"47","author":"He","year":"2006","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9394(14)74163-7","article-title":"Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS","volume":"103","author":"Henry","year":"1987","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib29","series-title":"Drug Product Development for the Back of the Eye. American Association of Pharmaceutical Scientist","first-page":"231","article-title":"Microparticles as drug delivery systems for the back of the eye","author":"Herrero-Vanrell","year":"2011"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib30","first-page":"60","article-title":"Ocular pharmacokinetic, drug bioavailability and intraocular drug delivery systems","author":"Herrero-Vanrell","year":"2010"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1773-2247(07)50002-X","article-title":"PLA and PLGA microparticles for intravitreal drug delivery: an overview","volume":"17","author":"Herrero-Vanrell","year":"2007","journal-title":"J.\u00a0Drug. Del. Sci. Tech."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib32","unstructured":"Herrero-Vanrell, R., Refojo, M.F., 1998. U.S. Patent 5,718,922."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(01)00200-9","article-title":"Biodegradable microspheres for vitreoretinal drug delivery","volume":"52","author":"Herrero-Vanrell","year":"2001","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib34","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1023\/A:1026464124412","article-title":"Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in\u00a0vitro release profiles, and sterilization process","volume":"17","author":"Herrero-Vanrell","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib35","series-title":"Invest Ophthalmol Vis Sci Annual Meeting. Fort Lauderdale, FL, USA. Abstract 5978","article-title":"PLGA microparticles loaded with neuroprotective agents (GDNF and BDNF). A potential treatment for glaucoma","author":"Herrero-Vanrell","year":"2009"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib36","series-title":"Invest Ophthalmol Vis Sci Annual Meeting. Fort Lauderdale, FL, USA. Abstract 5300","article-title":"Tolerance of juxtascleral administration of Sterilized PLGA Microparticles Unloaded and Loaded With Dexamethasone","author":"Herrero-Vanrell","year":"2010"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib37","first-page":"139","article-title":"Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema","volume":"5","author":"Herrero-Vanrell","year":"2011","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib38","series-title":"Invest Ophthalmol Vis Sci Annual Meeting. Fort Lauderdale, FL, USA. Abstract 3251","article-title":"Encapsulated TUDCA PLGA microspheres for the treatment of retinitis pigmentosa","author":"Herrero-Vanrell","year":"2011"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1773-2247(13)50016-5","article-title":"Nano and microtechnologies for ophthalmic administration, an overview","volume":"23","author":"Herrero-Vanrell","year":"2013","journal-title":"J.\u00a0Drug. Del. Sci. Tech."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archopht.1989.01070010077031","article-title":"Cytomegalovirus retinitis and acquired immunodeficiency syndrome","volume":"107","author":"Jabs","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib41","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/jps.22306","article-title":"A\u00a0two-stage strategy for sterilization of poly(lactide-co-glycolide) particles by gamma-irradiation does not impair their potency for vaccine delivery","volume":"100","author":"Jain","year":"2011","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib42","first-page":"1783","article-title":"Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma","volume":"13","author":"Jiang","year":"2007","journal-title":"Mol. Vis."},{"issue":"3","key":"10.1016\/j.preteyeres.2014.04.002_bib86","first-page":"175","article-title":"Clearance of sodium fluorescein incorporated into microspheres from the vitreous after intravitreal injection","volume":"22","author":"Khoobehi","year":"1991","journal-title":"Ophthalmic Surg."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib43","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1167\/iovs.02-0791","article-title":"Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression","volume":"44","author":"Kompella","year":"2003","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archopht.1992.01080140115038","article-title":"Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection","volume":"110","author":"Kwak","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib45","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1208\/s12249-011-9644-8","article-title":"Radiation and ethylene oxide terminal sterilization experiences with drug eluting stent products","volume":"12","author":"Lambert","year":"2011","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-3659(02)00239-0","article-title":"Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer","volume":"84","author":"Lee","year":"2002","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib47","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7","article-title":"Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids","volume":"48","author":"Li","year":"1999","journal-title":"J.\u00a0Biomed. Mater. Res."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib48","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3109\/02652040309178090","article-title":"Poly (D,L-lactide-co-glycolide) microspheres for long-term intravitreal delivery of aciclovir: influence of fatty and non-fatty additives","volume":"20","author":"Martinez-Sancho","year":"2003","journal-title":"J.\u00a0Microencapsul."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijpharm.2003.12.006","article-title":"Optimisation of aciclovir poly(D,L-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study","volume":"273","author":"Martinez-Sancho","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2004.06.004","article-title":"Study of gamma-irradiation effects on aciclovir poly(D,L-lactic-co-glycolic) acid microspheres for intravitreal administration","volume":"99","author":"Martinez-Sancho","year":"2004","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijpharm.2006.07.010","article-title":"Vitamin A palmitate and aciclovir biodegradable microspheres for intraocular sustained release","volume":"326","author":"Martinez-Sancho","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib52","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jbm.820110507","article-title":"Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA\/PGA copolymer ratios","volume":"11","author":"Miller","year":"1977","journal-title":"J.\u00a0Biomed. Mater. Res."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib53","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejpb.2011.10.007","article-title":"Encapsulation of antigen in poly(D,L-lactide.co-glycolide) microspheres proects from harmful effects of gamma-irradiation as assessed in mice","volume":"80","author":"Mohanan","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0168-3659(98)00082-0","article-title":"Gamma irradiation effects on poly(DL,-lactide-co-glycolide) microspheres","volume":"56","author":"Montanari","year":"1998","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib55","first-page":"1785","article-title":"Microspheres of biodegradable polymers as a drug-delivery system in the vitreous","volume":"32","author":"Moritera","year":"1991","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib56","first-page":"3125","article-title":"Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy","volume":"33","author":"Moritera","year":"1992","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib58","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0142-9612(01)00309-X","article-title":"Influence of neutron irradiation on holmium acetylacetonate loaded poly(L-lactic acid) microspheres","volume":"23","author":"Nijsen","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib59","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1167\/iovs.08-2920","article-title":"A\u00a0single intraoperative sub-tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery","volume":"50","author":"Paganelli","year":"2009","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib60","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1517\/17425247.2010.498817","article-title":"Controlled transscleral drug delivery formulations to the eye: establishing new concepts and paradigms in ocular anti-inflammatory therapeutics and antibacterial prophylaxis","volume":"7","author":"Paganelli","year":"2010","journal-title":"Expert Opin. Drug. Deliv."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s11095-010-0271-y","article-title":"Suprachoroidal drug delivery to the back of the eye using hollow microneedles","volume":"28","author":"Patel","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib62","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1167\/iovs.12-9872","article-title":"Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye","volume":"53","author":"Patel","year":"2012","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib63","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/ejn.12196","article-title":"Cone survival and preservation of visual acuity in an animal model of retinal degeneration","volume":"37","author":"Piano","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib64","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.addr.2006.07.025","article-title":"Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling","volume":"58","author":"Ranta","year":"2006","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jbm.a.30702","article-title":"Biocompatibility of elastin-like polymer poly(VPAVG) microparticles: in\u00a0vitro and in\u00a0vivo studies","volume":"78","author":"Rincon","year":"2006","journal-title":"J.\u00a0Biomed. Mater. Res. A"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/jop.2010.0082","article-title":"Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection","volume":"27","author":"Rodrigues","year":"2011","journal-title":"J.\u00a0Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib67","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archopht.1996.01100130585016","article-title":"Referral patterns of uveitis in a tertiary eye care center","volume":"114","author":"Rodriguez","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib68","series-title":"XXV Symposium of the European Society for Biomaterials","article-title":"Handling of PEA Microparticles for in\u00a0vivo intraocular injections","author":"Rojas","year":"2013"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib69","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1167\/iovs.03-0600","article-title":"Periocular injection of microspheres containing PKC412 inhibits choroidal neovascularization in a porcine model","volume":"44","author":"Saishin","year":"2003","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib70","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-5173(98)00274-9","article-title":"Influence of irradiation sterilization on a semi-solid poly(ortho ester)","volume":"175","author":"Sintzel","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib71","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/02652040400026400","article-title":"Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles","volume":"22","author":"Srinivasan","year":"2005","journal-title":"J.\u00a0Microencapsul."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib72","doi-asserted-by":"crossref","first-page":"18706","DOI":"10.1073\/pnas.1007644107","article-title":"Inhibition of ceramide biosynthesis preserves photoreceptor structure and function in a mouse model of retinitis pigmentosa","volume":"26","author":"Strettoi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.preteyeres.2014.04.002_bib73","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.exer.2006.02.012","article-title":"Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells","volume":"83","author":"Szurman","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib74","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1167\/iovs.03-1114","article-title":"Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice","volume":"45","author":"Tan","year":"2004","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib75","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-3659(98)00146-1","article-title":"Modification of release rates of cyclosporin A from polyl(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres","volume":"58","author":"Urata","year":"1999","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib76","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1444-0938.2008.00305.x","article-title":"Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practice","volume":"91","author":"van Wijngaarden","year":"2008","journal-title":"Clin. Exp. Optom."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib77","first-page":"665","article-title":"Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus","volume":"38","author":"Veloso","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib78","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jbm.820190315","article-title":"Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules","volume":"19","author":"Visscher","year":"1985","journal-title":"J.\u00a0Biomed. Mater. Res."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib81","first-page":"760","article-title":"Alternative methods of terminal sterilization for biologically active macromolecules","volume":"4","author":"Yaman","year":"2001","journal-title":"Curr. Opin. Drug. Discov. Devel."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib82","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.biomaterials.2010.09.063","article-title":"Robust cell integration from co-transplantation of biodegradable MMP2-PLGA microspheres with retinal progenitor cells","volume":"32","author":"Yao","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.preteyeres.2014.04.002_bib83","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.preteyeres.2004.02.003","article-title":"Drug delivery systems for vitreoretinal diseases","volume":"23","author":"Yasukawa","year":"2004","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187221111794109529","article-title":"Recent advances in intraocular drug delivery systems","volume":"5","author":"Yasukawa","year":"2011","journal-title":"Recent Pat. Drug. Deliv. Formul."},{"key":"10.1016\/j.preteyeres.2014.04.002_bib85","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0169-409X(95)00017-2","article-title":"Microspheres and nanoparticles used in ocular delivery systems","volume":"16","author":"Zimmer","year":"1995","journal-title":"Adv. Drug. Deliv. Rev."}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946214000263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946214000263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T03:22:17Z","timestamp":1538623337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946214000263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":83,"alternative-id":["S1350946214000263"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2014.04.002","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2014.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}